Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
EI-001 antibody treatment for nonsegmental vitiligo
Official title: A Phase 2, Randomized, Double-Blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of EI-001 in Patients With Nonsegmental Vitiligo
Status: Recruiting now
Description:
Elixiron Immunotherapeutics (Hong Kong) Ltd. plans to enroll about 45 participants. EI-001 is an experimental antibody that blocks interferon-gamma, an inflammatory signal involved in melanocyte damage. Researchers hope it will protect pigment-producing cells and support repigmentation. Possible risks include infusion or allergic reactions, headache, and infections; its full safety profile is not yet known. People ages 18 to 65 may qualify. The study is recruiting at 6 listed sites in United States, and Taiwan.
Start date: December 30, 2025
Completion date: September 30, 2027
Organizer: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Contact: Matthew Campos Site Coordinator
Tel.: 714-375-5970
Email: mcampos@marvelclinical.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Is there a traditional medicine to treat vitiligo?
Traditional remedies can be helpful for managing stress or general metabolic health, but when it comes to vitiligo, the evidence is limited. While some natural supplements provi...
- Which therapy has minimal side-effects?
Dead Sea climatotherapy is a unique and highly effective treatment option for vitiligo, offering a top-tier safety profile and natural therapeutic benefits. Its combination of p...
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.